Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
In the dynamic landscape of medical treatments, informed decisions are paramount
Most GLP-1a weight loss and type diabetes medications require a prior authorization (PA) from the insurance provider: FDA-approved weight loss medications: Contrave, Saxenda (liraglutide), Wegovy (semaglutide) Zepbound (tirzepatide) FDA-approved Diabetes medications: Rybelsis, Victoza (liraglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide) If your insurance company says that they cover FDA-approved diabetes medications, it suggests coverage for patients with type 2 diabetes
Over the past few years, Ive been watching the research closely and observing first hand how these medications affect my clients, especially their gut microbiome
The FDA's MedWatch program encourages reporting of any suspected adverse events in patients taking Zepbound to contribute to ongoing safety monitoring
Studies suggest that Wegovy and Rybelsus may also worsen diabetic retinopathy and macular complications
Improving mood: Research published in 2023 suggests that omega-3s, which are found in fish oil, may reduce symptoms of depression
